Search Results - "Menko, FH"

Refine Results
  1. 1

    Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis by Smit, DL, Mensenkamp, AR, Badeloe, S, Breuning, MH, Simon, MEH, Van Spaendonck, KY, Aalfs, CM, Post, JG, Shanley, S, Krapels, IPC, Hoefsloot, LH, Van Moorselaar, RJA, Starink, TM, Bayley, J-P, Frank, J, Van Steensel, MAM, Menko, FH

    Published in Clinical genetics (01-01-2011)
    “…Smit DL, Mensenkamp AR, Badeloe S, Breuning MH, Simon MEH, van Spaendonck KY, Aalfs CM, Post JG, Shanley S, Krapels IPC, Hoefsloot LH, van Moorselaar RJA,…”
    Get full text
    Journal Article
  2. 2

    Cancer risks in BRCA2 families: estimates for sites other than breast and ovary by van Asperen, C J, Brohet, R M, Meijers-Heijboer, E J, Hoogerbrugge, N, Verhoef, S, Vasen, H F A, Ausems, M G E M, Menko, F H, Gomez Garcia, E B, Klijn, J G M, Hogervorst, F B L, van Houwelingen, J C, van’t Veer, L J, Rookus, M A, van Leeuwen, F E

    Published in Journal of medical genetics (01-09-2005)
    “…Background: In BRCA2 mutation carriers, increased risks have been reported for several cancer sites besides breast and ovary. As most of the families included…”
    Get full text
    Journal Article
  3. 3

    Do Preferred Risk Formats Lead to Better Understanding? A Multicenter Controlled Trial on Communicating Familial Breast Cancer Risks Using Different Risk Formats by Henneman, Lidewij, van Asperen, Christi J, Oosterwijk, Jan C, Menko, Fred H, Claassen, Liesbeth, Timmermans, Daniëlle Rm

    Published in Patient preference and adherence (01-01-2020)
    “…Counselees' preferences are considered important for the choice of risk communication format and for improving patient-centered care. We here report on…”
    Get full text
    Journal Article
  4. 4

    Birt-Hogg-Dubé syndrome: diagnosis and management by Menko, Fred H, Dr, van Steensel, Maurice AM, MD, Giraud, Sophie, MD, Friis-Hansen, Lennart, MD, Richard, Stéphane, Prof, Ungari, Silvana, MD, Nordenskjöld, Magnus, Prof, Hansen, Thomas vO, MSc, Solly, John, PhD, Maher, Eamonn R, Prof

    Published in The lancet oncology (01-12-2009)
    “…Summary Birt-Hogg-Dubé syndrome (BHD) is an autosomal dominant condition characterised clinically by skin fibrofolliculomas, pulmonary cysts, spontaneous…”
    Get full text
    Journal Article
  5. 5

    Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer by Piek, Jurgen M. J., van Diest, Paul J., Zweemer, Ronald P., Jansen, Jan W., Poort-Keesom, Ria J. J., Menko, Fred H., Gille, Johan J. P., Jongsma, Ans P. M., Pals, Gerard, Kenemans, Peter, Verheijen, René H. M.

    Published in The Journal of pathology (01-11-2001)
    “…The aim of this study was to investigate the occurrence of (pre)neoplastic lesions in overtly normal Fallopian tubes from women predisposed to developing…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    MSH2 Mutation Carriers Are at Higher Risk of Cancer Than MLH1 Mutation Carriers: A Study of Hereditary Nonpolyposis Colorectal Cancer Families by VASEN, H. F. A, STORMORKEN, A, MENKO, F. H, NAGENGAST, F. M, KLEIBEUKER, J. H, GRIFFIOEN, G, TAAL, B. G, MOLLER, P, WIJNEN, J. T

    Published in Journal of clinical oncology (15-10-2001)
    “…Hereditary nonpolyposis colorectal cancer (HNPCC) is an autosomal dominant disease characterized by the clustering of colorectal cancer, endometrial cancer,…”
    Get full text
    Journal Article
  9. 9

    Low penetrance of paraganglioma and pheochromocytoma in an extended kindred with a germline SDHB exon 3 deletion by Rijken, J.A., Niemeijer, N.D., Corssmit, E.P.M., Jonker, M.A., Leemans, C.R., Menko, F.H., Hensen, E.F.

    Published in Clinical genetics (01-01-2016)
    “…In the Netherlands, the majority of hereditary paragangliomas (PGL) is caused by SDHD, SDHB and SDHAF2 mutations. Founder mutations in SDHD are particularly…”
    Get full text
    Journal Article
  10. 10

    Absence of the Birt-Hogg-Dubé gene product is associated with increased hypoxia-inducible factor transcriptional activity and a loss of metabolic flexibility by Preston, R S, Philp, A, Claessens, T, Gijezen, L, Dydensborg, A B, Dunlop, E A, Harper, K T, Brinkhuizen, T, Menko, F H, Davies, D M, Land, S C, Pause, A, Baar, K, van Steensel, M A M, Tee, A R

    Published in Oncogene (10-03-2011)
    “…Under conditions of reduced tissue oxygenation, hypoxia-inducible factor (HIF) controls many processes, including angiogenesis and cellular metabolism, and…”
    Get full text
    Journal Article
  11. 11

    The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC by De Jong, Andrea E, Morreau, Hans, Van Puijenbroek, Marjo, Eilers, Paul H c, Wijnen, Juul, Nagengast, Fokko M, Griffioen, Gerrit, Cats, Annemieke, Menko, Fred H, Kleibeuker, Jan H, Vasen, Hans F A

    Published in Gastroenterology (New York, N.Y. 1943) (01-01-2004)
    “…The adenoma-carcinoma sequence in hereditary nonpolyposis colorectal cancer (HNPCC) is accelerated. It remains unknown whether the mismatch repair (MMR) defect…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Screening behavior of individuals at high risk for colorectal cancer by Bleiker, Eveline M.A., Menko, Fred H., Taal, Babs G., Kluijt, Irma, Wever, Lidwina D.V., Gerritsma, Miranda A., Vasen, Hans F.A., Aaronson, Neil K.

    Published in Gastroenterology (New York, N.Y. 1943) (01-02-2005)
    “…Background & Aims: Periodic colonoscopy is an effective means of reducing the incidence and mortality of colorectal cancer in individuals with a family history…”
    Get full text
    Journal Article
  14. 14

    Perceiving cancer-risks and heredity-likelihood in genetic-counseling: how counselees recall and interpret BRCA 1/2-test results by Vos, J, Oosterwijk, JC, Gómez-García, E, Menko, FH, Jansen, AM, Stoel, RD, van Asperen, CJ, Tibben, A, Stiggelbout, AM

    Published in Clinical genetics (01-03-2011)
    “…Vos J, Oosterwijk JC, Gómez‐García E, Menko FH, Jansen AM, Stoel RD, van Asperen CJ, Tibben A, Stiggelbout AM. Perceiving cancer‐risks and heredity‐likelihood…”
    Get full text
    Journal Article
  15. 15

    Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach by GILLE, J. J. P, HOGERVORST, F. B. L, MCELGUNN, C. J, SCHOUTEN, J. P, MENKO, F. H, PALS, G, WIJNEN, J. Th, VAN SCHOOTEN, R. J, DOMMERING, C. J, MEIJER, G. A, CRAANEN, M. E, NEDERLOF, P. M, DE JONG, D

    Published in British journal of cancer (07-10-2002)
    “…Hereditary non-polyposis colorectal cancer is an autosomal dominant condition due to germline mutations in DNA-mismatch-repair genes, in particular MLH1, MSH2…”
    Get full text
    Journal Article
  16. 16

    Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis by Vasen, HF, Wijnen, JT, Menko, FH, Kleibeuker, JH, Taal, BG, Griffioen, G, Nagengast, FM, Meijers-Heijboer, EH, Bertario, L, Varesco, L, Bisgaard, ML, Mohr, J, Fodde, R, Khan, PM

    Published in Gastroenterology (New York, N.Y. 1943) (01-04-1996)
    “…BACKGROUND & AIMS: Hereditary nonpolyposis colorectal cancer is characterized by early-onset colorectal cancer and the occurrence of various other cancers. The…”
    Get full text
    Journal Article Conference Proceeding
  17. 17

    Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect by de Vos tot Nederveen Cappel, W H, Buskens, E, van Duijvendijk, P, Cats, A, Menko, F H, Griffioen, G, Slors, J F, Nagengast, F M, Kleibeuker, J H, Vasen, H F A

    Published in Gut (01-12-2003)
    “…Background: In view of the high risk of developing a new primary colorectal carcinoma (CRC), subtotal colectomy rather than segmental resection or…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Childhood brain tumours due to germline bi-allelic mismatch repair gene mutations by Johannesma, PC, van der Klift, HM, van Grieken, NCT, Troost, D, te Riele, H, Jacobs, MAJM, Postma, TJ, Heideman, DAM, Tops, CMJ, Wijnen, JT, Menko, FH

    Published in Clinical genetics (01-09-2011)
    “…Johannesma PC, van der Klift HM, van Grieken NCT, Troost D, te Riele H, Jacobs MAJM, Postma TJ, Heideman DAM, Tops CMJ, Wijnen JT, Menko FH. Childhood brain…”
    Get full text
    Journal Article
  20. 20

    Survival after adjuvant 5‐FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer by de Vos tot Nederveen Cappel, Wouter H., Meulenbeld, Hielke J., Kleibeuker, Jan H., Nagengast, Fokko M., Menko, Fred H., Griffioen, Gerrit, Cats, Annemiek, Morreau, Hans, Gelderblom, Hans, Vasen, Hans F.A.

    Published in International journal of cancer (10-04-2004)
    “…In vitro studies suggest that a deficient mismatch repair (MMR) system reduces 5‐Fluorouracil cytotoxicity. Colon cancer (CC) in hereditary nonpolyposis…”
    Get full text
    Journal Article